ATE209922T1 - Pharmazeutische zusammensetzung von stickstoffmonoxid - Google Patents
Pharmazeutische zusammensetzung von stickstoffmonoxidInfo
- Publication number
- ATE209922T1 ATE209922T1 AT96934916T AT96934916T ATE209922T1 AT E209922 T1 ATE209922 T1 AT E209922T1 AT 96934916 T AT96934916 T AT 96934916T AT 96934916 T AT96934916 T AT 96934916T AT E209922 T1 ATE209922 T1 AT E209922T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- nitrogen monoxide
- pharmaceutical composition
- date
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512345 | 1995-10-20 | ||
PCT/FR1996/001610 WO1997015311A1 (fr) | 1995-10-20 | 1996-10-15 | Composition a base de monoxyde d'azote en tant que medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209922T1 true ATE209922T1 (de) | 2001-12-15 |
Family
ID=9483741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96934916T ATE209922T1 (de) | 1995-10-20 | 1996-10-15 | Pharmazeutische zusammensetzung von stickstoffmonoxid |
Country Status (9)
Country | Link |
---|---|
US (2) | US6051241A (de) |
EP (2) | EP0855912B1 (de) |
JP (2) | JPH11513703A (de) |
AT (1) | ATE209922T1 (de) |
AU (2) | AU701760B2 (de) |
CA (1) | CA2188238A1 (de) |
DE (1) | DE69617719D1 (de) |
ES (1) | ES2167608T3 (de) |
WO (2) | WO1997015311A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6106497A (en) * | 1997-01-31 | 2000-08-22 | Medical Instrument Development Laboratories | System and method for preventing an air embolism in a surgical procedure |
EP0887076A3 (de) * | 1997-05-07 | 1999-03-31 | Saturnus A.G. | Verhinderung von Gewebeverklebung und ein dafür vorgesehenes endoskopisches System zum Aufblasen einer Körperhöhle |
US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
FR2775967B1 (fr) * | 1998-03-10 | 2000-06-23 | Air Liquide | Melange gazeux conditionne supercritique contenant du co2, du no et eventuellement du gaz neutre |
DE19833014A1 (de) * | 1998-07-23 | 2000-01-27 | Messer Griesheim Gmbh | Edelgashaltige Injektionsanästhesiemittel |
US6503740B1 (en) | 2000-02-22 | 2003-01-07 | Biomin, Inc. | Organically modified mineral materials containing engrafted bacteria for chemical contaminant decomposition |
AU2001249221A1 (en) * | 2000-03-20 | 2001-10-03 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
US20040225275A1 (en) * | 2001-08-02 | 2004-11-11 | Reynolds James Dixon | Fetal physiology during maternal surgery or diagnosis |
US6676855B2 (en) * | 2001-08-02 | 2004-01-13 | Duke University | Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
EP1515732B1 (de) * | 2002-06-12 | 2009-01-14 | Air Liquide Deutschland GmbH | Cerebrale protektion mit einem xenonhaltigen gas |
CN1668316A (zh) * | 2002-06-12 | 2005-09-14 | 梅瑟·格里斯海姆有限公司 | 含氙的解痉药 |
JP2006508040A (ja) * | 2002-07-05 | 2006-03-09 | メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | キセノンを含有するアジュバント |
DE10336768B4 (de) * | 2002-08-10 | 2010-09-09 | Air Liquide Deutschland Gmbh | Medikament zur Verbesserung der Sauerstoffutilation |
WO2004039415A2 (en) | 2002-10-28 | 2004-05-13 | Northgate Technologies Inc. | Dual-capacity insufflator tube |
US7654975B2 (en) * | 2003-04-24 | 2010-02-02 | Northgate Technologies, Inc. | Mixed-gas insufflation system |
ES2336796T3 (es) * | 2003-10-07 | 2010-04-16 | Northgate Technologies Incorporated | Sistema para suministrar una sustancia a una cavitacion corporal. |
US7914517B2 (en) * | 2003-10-31 | 2011-03-29 | Trudell Medical International | System and method for manipulating a catheter for delivering a substance to a body cavity |
CN100475275C (zh) * | 2004-01-05 | 2009-04-08 | 董永华 | 肿瘤血管栓塞剂及其储存和释放装置 |
SE0402221D0 (sv) | 2004-09-14 | 2004-09-14 | Aerocrine Ab | Treatment of insufficient perfusion |
WO2006089028A2 (en) * | 2005-02-15 | 2006-08-24 | Lab39, Llc | Foaming compositions and methods |
CA2933737C (en) * | 2006-08-04 | 2020-12-29 | Northgate Technologies Inc. | In-dwelling port for access into a body |
JP5581500B2 (ja) | 2010-03-10 | 2014-09-03 | 学校法人北里研究所 | 虚血再灌流障害軽減用治療剤および治療装置 |
US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
WO2012151583A1 (en) * | 2011-05-05 | 2012-11-08 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
CN110464709A (zh) | 2012-08-10 | 2019-11-19 | 德克萨斯州大学系统董事会 | 用于治疗中风的神经保护性脂质体组合物和方法 |
WO2014145443A2 (en) | 2013-03-15 | 2014-09-18 | The Board Of Regents Of The University Of Texas System | Liquids rich in noble gas and methods of their preparation and use |
US9486600B2 (en) | 2013-06-28 | 2016-11-08 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with inhalation valves communicating with a deformable reservoir |
US9522248B2 (en) | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage |
US9522247B2 (en) | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of treating a patient having pulmonary hypertension by long term NO therapy |
US9492626B2 (en) | 2013-06-28 | 2016-11-15 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance assemblies suitable for long term no therapy |
US9517318B2 (en) | 2013-06-28 | 2016-12-13 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir |
US9566407B2 (en) | 2013-06-28 | 2017-02-14 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with flow control passage communicating with a deformable reservoir |
US10471094B2 (en) | 2013-08-05 | 2019-11-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury via targeted control of blood gases |
US9572595B1 (en) | 2014-03-05 | 2017-02-21 | Northgate Technologies Inc. | In-dwelling port for access into a body |
GB2579240B (en) | 2018-11-27 | 2020-12-16 | Attgeno Ab | New processes, compositions and medical uses |
GB202007929D0 (en) | 2020-05-27 | 2020-07-08 | Attgeno Ab | New medical uses |
CN111840583B (zh) * | 2020-08-06 | 2023-03-28 | 温州医科大学 | 血管内皮损伤治疗的药物制剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443826A (en) * | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
CA2097823C (en) * | 1990-12-05 | 1999-06-29 | Warren M. Zapol | Therapy for pulmonary vasoconstriction and asthma |
US5536241A (en) * | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
US5427797A (en) * | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
-
1996
- 1996-10-15 JP JP9516340A patent/JPH11513703A/ja not_active Ceased
- 1996-10-15 WO PCT/FR1996/001610 patent/WO1997015311A1/fr active IP Right Grant
- 1996-10-15 AU AU73051/96A patent/AU701760B2/en not_active Ceased
- 1996-10-15 AT AT96934916T patent/ATE209922T1/de not_active IP Right Cessation
- 1996-10-15 ES ES96934916T patent/ES2167608T3/es not_active Expired - Lifetime
- 1996-10-15 EP EP96934916A patent/EP0855912B1/de not_active Expired - Lifetime
- 1996-10-15 DE DE69617719T patent/DE69617719D1/de not_active Expired - Lifetime
- 1996-10-17 EP EP96934928A patent/EP0859620A1/de not_active Ceased
- 1996-10-17 JP JP9516344A patent/JPH11513705A/ja active Pending
- 1996-10-17 AU AU73058/96A patent/AU7305896A/en not_active Abandoned
- 1996-10-17 WO PCT/FR1996/001624 patent/WO1997015312A1/fr not_active Application Discontinuation
- 1996-10-17 US US09/051,641 patent/US6051241A/en not_active Expired - Fee Related
- 1996-10-18 CA CA002188238A patent/CA2188238A1/fr not_active Abandoned
- 1996-10-18 US US08/733,919 patent/US5670177A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69617719D1 (de) | 2002-01-17 |
US6051241A (en) | 2000-04-18 |
EP0859620A1 (de) | 1998-08-26 |
WO1997015311A1 (fr) | 1997-05-01 |
JPH11513705A (ja) | 1999-11-24 |
WO1997015312A1 (fr) | 1997-05-01 |
EP0855912B1 (de) | 2001-12-05 |
ES2167608T3 (es) | 2002-05-16 |
AU7305896A (en) | 1997-05-15 |
CA2188238A1 (fr) | 1997-04-21 |
US5670177A (en) | 1997-09-23 |
AU7305196A (en) | 1997-05-15 |
AU701760B2 (en) | 1999-02-04 |
JPH11513703A (ja) | 1999-11-24 |
EP0855912A1 (de) | 1998-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209922T1 (de) | Pharmazeutische zusammensetzung von stickstoffmonoxid | |
GEP20002300B (en) | Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof | |
ATE326867T1 (de) | Freie aminosäure enthaltende zusammensetzung | |
HUP9902105A2 (hu) | Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása | |
MY130157A (en) | Method of use for inhibiting bone loss and lowering serum cholesterol | |
ATE292982T1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten | |
DK0706378T3 (da) | Ny farmaceutisk formulering. | |
KR950703968A (ko) | 외상 손상과 관련된 신경학적 병변의 치료에서 카르바마제핀 및 옥스카르바제핀의 적용(application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries) | |
HUT77380A (hu) | Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére | |
GB8712073D0 (en) | Medicament | |
NO2012003I2 (no) | 4-aminopyridin | |
CZ285522B6 (cs) | Farmaceutický prostředek pro snížení koncentrace glukosy v krvi | |
PL309604A1 (en) | Pharmaceutical composition for treating nicotin dependence | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
MX9708800A (es) | Compuestos biciclicos aromaticos. | |
CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
Alon et al. | Double-blind study of the reversal of midazolam-supplemented general anaesthesia with Ro 15–1788 | |
NO981136D0 (no) | Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
DK0668077T3 (da) | Produkter, som indeholder G-CSF og TNF-bindende protein | |
NO994259L (no) | Anvendelse av levobupivakain ved pediatrisk kirurgi | |
TR200101163T2 (tr) | Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları | |
DK492989A (da) | Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf | |
ATE243527T1 (de) | Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |